Evid Invest
Who owns SNDXWhat SNDX owns — n/a

Who owns Syndax Pharmaceuticals Inc?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of SNDX from SEC Form 13F filings across 237 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 237 institutions disclosed 98.7M shares of Syndax Pharmaceuticals Inc worth $1.83B — about 109.9% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.

237

13F holders

$1.83B

value, 2026 filers

109.9%

of shares outstanding (98.7M sh)

35

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of SNDX's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1BlackRock, Inc.9.3M$174.2M0.0%10.3%+2.8%
2Kynam Capital Management, LP8.2M$153.2M8.5%9.1%+1.2%
3GOLDMAN SACHS GROUP INC5.5M$103.8M0.0%6.2%-5.8%
4STATE STREET CORP4.7M$87.5M0.0%5.2%-17.8%
5VANGUARD CAPITAL MANAGEMENT LLC4.0M$74.3M0.0%4.4%+0.7%
6BANK OF AMERICA CORP /DE/3.8M$71.5M0.0%4.2%-6.0%
7DEERFIELD MANAGEMENT COMPANY, L.P.3.8M$71.1M1.1%4.2%0.0%
8FRANKLIN TEMPLETON INC3.5M$36.4M0.0%3.9%+52.4%
9Hood River Capital Management LLC2.6M$48.8M0.4%2.9%+1.3%
10Eversept Partners, LP2.4M$45.9M2.5%2.7%-12.7%
11GEODE CAPITAL MANAGEMENT, LLC2.3M$43.5M0.0%2.6%-10.6%
12KINGDON CAPITAL MANAGEMENT, L.L.C.2.2M$42.2M3.7%2.5%-10.2%
13VANGUARD PORTFOLIO MANAGEMENT LLC2.2M$41.7M0.0%2.5%+15.6%
14BNP PARIBAS ASSET MANAGEMENT Holding S.A.1.9M$36.2M0.0%2.1%+7.5%
15Candriam S.C.A.1.7M$31.5M0.1%1.9%-1.5%
16Elmind Capital, LP1.6M$30.2M7.5%1.8%-13.5%
17TWO SIGMA INVESTMENTS, LP1.5M$27.6M0.0%1.6%-7.0%
18LOOMIS SAYLES & CO L P1.3M$25.1M0.0%1.5%+44.6%
19Woodline Partners LP1.3M$25.0M0.1%1.5%+6.4%
20Aisling Capital Management LP1.3M$24.8M8.3%1.5%0.0%
21MILLENNIUM MANAGEMENT LLC1.2M$22.9M0.0%1.4%-40.6%
22UBS Group AG1.1M$21.5M0.0%1.3%-39.5%
23AQR CAPITAL MANAGEMENT LLC1.1M$21.5M0.0%1.3%+33.7%
24ALGERT GLOBAL LLC1.1M$20.9M0.3%1.2%+5.9%
25Parkman Healthcare Partners LLC1.1M$20.8M1.9%1.2%+26.0%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.